PLX
Protalix BioTherapeutics Inc.

16,423
Loading...
Loading...
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
213

Frequently Asked Questions

What is Market Cap of Protalix BioTherapeutics Inc.?
What is the 52-week high for Protalix BioTherapeutics Inc.?
What is the 52-week low for Protalix BioTherapeutics Inc.?
What is Protalix BioTherapeutics Inc. stock price today?
What was Protalix BioTherapeutics Inc. stock price yesterday?
What is the PE ratio of Protalix BioTherapeutics Inc.?
What is the Price-to-Book ratio of Protalix BioTherapeutics Inc.?
What is the 50-day moving average of Protalix BioTherapeutics Inc.?
How many employess does Protalix BioTherapeutics Inc. has?

Latest PLX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.